Amgen Inc. buy Argus
Start price
17.10.23
/
50%
€269.00
Target price
17.10.24
€293.01
Performance (%)
9.94%
End price
18.10.24
€295.75
Summary
This prediction ended on 18.10.24 with a price of €295.75. With a performance of 9.94%, the BUY prediction by Argus for Amgen Inc. closed with a slight gain. Argus has a follow-up prediction for Amgen Inc. where he still thinks Amgen Inc. is a Buy. Dividends of €8.16 are taken into consideration when calculating the performance. Argus has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Amgen Inc. | -0.244% | -0.244% | 7.554% |
| iShares Core DAX® | -1.034% | -9.171% | -1.558% |
| iShares Nasdaq 100 | -1.947% | -2.616% | 11.249% |
| iShares Nikkei 225® | -0.425% | -9.424% | 24.931% |
| iShares S&P 500 | -1.201% | -2.986% | 7.515% |
Comments by Argus for this prediction
In the thread Amgen Inc. diskutieren
Amgen Inc. (NASDAQ: AMGN) had its price target raised by analysts at Argus from $280.00 to $310.00. They now have a "buy" rating on the stock.
Ratings data for AMGN provided by MarketBeat
In the thread Trading Amgen Inc.
Die von Argus gewählte maximale Laufzeit wurde überschritten